Login / Signup

Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice.

Massimo PuatoAlberto ZambonChiara NardinElisabetta FagginRaffaele PesaventoAlice SpinazzèPaolo PaulettoMarcello Rattazzi
Published in: Cardiovascular therapeutics (2021)
A long-term treatment with a combination of RYR and coenzyme Q10 showed lipid-lowering activity along with a reduction of inflammatory mediators and an improvement of vascular properties in young subjects with a low-to-moderate CV risk profile.
Keyphrases
  • middle aged
  • high intensity
  • saccharomyces cerevisiae
  • combination therapy
  • replacement therapy